Moe Alsumidaie is a clinical research innovator, data scientist, and AI-driven strategist with nearly two decades of experience shaping the future of clinical trials. As Chief Editor of The Clinical Trial Vanguard, Moe delivers cutting-edge insights, investigative journalism, and deep industry analysis, ensuring professionals stay ahead in an evolving clinical research landscape.
At CliniBiz, Moe serves as Head of Research, leveraging automation, analytics, and AI to optimize clinical trial operations, patient recruitment, and site-sponsor collaborations. By integrating technology with trial execution, CliniBiz accelerates study startup, improves data quality, and reduces costs.
As Chief Data Scientist at Annex Clinical, Moe pioneers custom-built AI and data solutions that empower sponsors, CROs, and research organizations to harness their data for predictive modeling, budget optimization, and operational efficiency.
His expertise spans data integration, AI-driven automation, and risk-based analytics, enabling the seamless execution of clinical trials with enhanced accuracy and scalability.
Moe has held key roles at Genentech, Roche, and Mount Sinai Health System, overseeing global clinical trial operations, pioneering risk-based monitoring, and optimizing clinical trial budgets through advanced analytical models. His work has led to significant cost savings, operational efficiencies, and improved trial outcomes.
A recognized speaker, educator, and contributing columnist, Moe has served on the Editorial Advisory Board for Applied Clinical Trials Magazine, guest lectured at Rutgers University, and consulted on clinical research innovation strategies.
With a track record of launching AI-powered technologies, commercializing eClinical platforms, and driving industry transformation, Moe continues to push the boundaries of how data science and automation can reshape the future of clinical research.
Contact Form